Endocannabinoids in Appetite Control and the Treatment of Obesity

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 3, 2006-06 ,pp. : 275-292

Bentham Science Publishers

Access to resources Recommend Favorite

Endocannabinoids

By Mechoulam R.   Fride E.   Di Marzo V.  

European Journal of Pharmacology, Vol. 359, Iss. 1, 1998-10 ,pp. : 1-18

Elsevier

Access to resources Recommend Favorite

Activation and Control of CNS Innate Immune Responses in Health and Diseases: A Balancing Act Finely Tuned by Neuroimmune Regulators (NIReg)

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 1, 2011-02 ,pp. : 25-43

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning

By Mennicken F.   Maki R.   de Souza E.B.   Quirion R.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 2, 1999-02 ,pp. : 73-78

Elsevier

Access to resources Recommend Favorite

Endocannabinoids Part II: pathological CNS conditions involving the endocannabinoid system and their possible treatment with endocannabinoid-based drugs

By Di Marzo Vincenzo   Bisogno Tiziana   Petrocellis Luciano De  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 3, 2001-06 ,pp. : 349-362

Informa Healthcare

Access to resources Recommend Favorite